Detalles de la búsqueda
1.
The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis.
Pharmacol Res
; 203: 107157, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531504
2.
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Calcif Tissue Int
; 113(2): 175-185, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099141
3.
Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross-sectional data.
Diabetes Obes Metab
; 25 Suppl 1: 5-12, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811222
4.
Association between biologic therapy and fracture incidence in patients with selected rheumatic and autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials.
Pharmacol Res
; 181: 106278, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644324
5.
The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis.
Mediators Inflamm
; 2021: 7712587, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34504395
6.
LAG3 (CD223) and autoimmunity: Emerging evidence.
J Autoimmun
; 112: 102504, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32576412
7.
Weight reduction and the risk of gallbladder and biliary disease: A systematic review and meta-analysis of randomized clinical trials.
Obes Rev
; 25(6): e13725, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346789
8.
Diminished LAG3+ B cells correlate with exacerbated rheumatoid arthritis.
Ann Med
; 55(1): 2208373, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37143367
9.
Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis.
EClinicalMedicine
; 57: 101868, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36864984
10.
Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
Atherosclerosis
; 379: 117181, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37527612
11.
Baseline eGFR, albuminuria and renal outcomes in patients with SGLT2 inhibitor treatment: an updated meta-analysis.
Acta Diabetol
; 60(3): 435-445, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36609865
12.
The correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Expert Opin Pharmacother
; 24(4): 511-521, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36799287
13.
Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?
Eur J Intern Med
; 109: 79-88, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36628824
14.
Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis.
World J Diabetes
; 14(10): 1573-1584, 2023 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37970134
15.
Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials.
Front Pharmacol
; 13: 1018720, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36483741
16.
The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysis.
Expert Rev Clin Pharmacol
; 15(7): 877-886, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839519
17.
Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participants.
Expert Opin Investig Drugs
; 31(9): 957-964, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35968648
18.
The Urinary Glucose Excretion by Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Different Levels of Renal Function: A Systematic Review and Meta-Analysis.
Front Endocrinol (Lausanne)
; 12: 814074, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35154011
19.
SGLT2i increased the plasma fasting glucagon level in patients with diabetes: A meta-analysis.
Eur J Pharmacol
; 903: 174145, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957085
20.
The Effect of Physical Activity on Glycemic Variability in Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Front Endocrinol (Lausanne)
; 12: 767152, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34867812
Resultados
1 -
20
de 20
1
Próxima >
>>